[A new bacterioclinical entity: Ristella pseudoinsolita infection].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001064:Appendicitis; D001439:Bacteroides; D002701:Chloramphenicol / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D007239:Infections; D007933:Leucomycins / Q000627:therapeutic use; D009827:Oleandomycin / Q000627:therapeutic use; D010118:Oxytetracycline / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D007933:Leucomycins; D004917:Erythromycin; D002701:Chloramphenicol; D013752:Tetracycline; D009827:Oleandomycin; D010118:Oxytetracycline
Une nouvelle entité bactério-clinique: l'infection à Ristella pseudoinsolita.